(Q31045955)

28 June 2017

title

Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model (English)

1 reference

28 June 2017

0 references

Yuzhang Wu

1

1 reference

28 June 2017

Ying Wan

2

1 reference

28 June 2017

Jiang Bian

3

1 reference

28 June 2017

Jianping Zhao

4

1 reference

28 June 2017

ZhengCai Jia

5

1 reference

28 June 2017

Liyun Zhou

6

1 reference

28 June 2017

Wei Zhou

7

1 reference

28 June 2017

Yang Tan

8

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

International Journal of Cancer

28 June 2017

published in

1 reference

28 June 2017

volume

98

1 reference

28 June 2017

issue

5

1 reference

28 June 2017

page(s)

748-753

1 reference

Human tumor antigens for cancer vaccine development

28 June 2017

cites work

1 reference

Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma

21 January 2018

1 reference

Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine

21 January 2018

1 reference

Design of specific immunogens using filamentous phage as the carrier.

21 January 2018

1 reference

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector.

21 January 2018

1 reference

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

Serological identification of human tumor antigens

21 January 2018

1 reference

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

Hybrid cell vaccination for cancer immunotherapy

21 January 2018

1 reference

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

21 January 2018

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

Cytotoxic T lymphocytes specific for the simian immunodeficiency virus

21 January 2018

1 reference

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

21 January 2018

1 reference

Development of non-live vectors and procedures (liposomes, pseudo-viral particles, toxin, beads, adjuvantsellipsis) as tools for cancer vaccines.

21 January 2018

1 reference

Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes

21 January 2018

1 reference

Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model

21 January 2018

1 reference

Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses.

21 January 2018

1 reference

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

21 January 2018

1 reference

Filamentous phage structure, infection and assembly

21 January 2018

1 reference

Factors limiting display of foreign peptides on the major coat protein of filamentous bacteriophage capsids and a potential role for leader peptidase

21 January 2018

1 reference

Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses

21 January 2018

1 reference

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

21 January 2018

1 reference

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

21 January 2018

1 reference

Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages

21 January 2018

1 reference

The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection

21 January 2018

1 reference

MHC-binding peptides as immunotherapeutics for cancer

21 January 2018

1 reference

Lipopeptide particles as the immunologically active component of CTL inducing vaccines

21 January 2018

1 reference

Fully mobilizing host defense: building better vaccines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10260

1 reference

28 June 2017

1 reference